| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/24/1999 | CA2315295A1 110 human secreted proteins |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | CA2315251A1 Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides |
| 06/24/1999 | CA2315247A1 Mammalian calcitonin-like polypeptide-1 |
| 06/24/1999 | CA2314909A1 Human nap1 protein |
| 06/24/1999 | CA2314884A1 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | CA2314379A1 Human dendriac and brainiac-3 |
| 06/24/1999 | CA2314319A1 Novel surface protein of neisseria meningitidis |
| 06/24/1999 | CA2313391A1 Human rad1 nucleic acid, polypeptides, assays, therapeutic methods and means |
| 06/24/1999 | CA2311572A1 Extended cdnas for secreted proteins |
| 06/23/1999 | EP0924298A1 Protein expression in baculovirus vector expression systems |
| 06/23/1999 | EP0924297A1 Sialoadhesin family member-2 (saf-2) |
| 06/23/1999 | EP0924295A2 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 06/23/1999 | EP0923941A2 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 06/23/1999 | EP0923740A2 Methods and compositions for the detection of cervical cancer |
| 06/23/1999 | EP0923644A1 G-coupled receptor showing selective affinity for atp |
| 06/23/1999 | EP0923641A2 A process for preparing beta-fructofuranosidase and use in the synthesis of fructooligosaccharides |
| 06/23/1999 | EP0923607A1 Method for producing polyclonal and monoclonal antibodies |
| 06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
| 06/23/1999 | EP0923602A1 Immunocontraceptive compositions containing sperm antigens, and methods of use |
| 06/23/1999 | EP0693078B1 Dna polymerases with enhanced thermostability and enhanced length and efficiency of primer extension |
| 06/23/1999 | EP0690876B1 Protein kinases |
| 06/23/1999 | EP0628639B1 Reconstituted human antibody against human interleukin 6 receptor |
| 06/23/1999 | EP0605522B1 Methods for the production of humanized antibodies |
| 06/23/1999 | EP0598816B1 Osp a proteins of borrelia burgdorferi subgroups, encoding genes and vaccines |
| 06/23/1999 | EP0559725B1 Structural proteins from artificial genes |
| 06/23/1999 | EP0496818B1 MONOCLONAL ANTIBODY SPECIFIC FOR IgA RECEPTOR |
| 06/23/1999 | CN1220701A Lipid kinase |
| 06/23/1999 | CN1220699A Antibodies against interferon alpha/beta receptor |
| 06/23/1999 | CN1220314A Cytochrome C and its gene |
| 06/23/1999 | CA2255140A1 Echinocandin binding domain of 1,3-.beta.-glucan synthase |
| 06/22/1999 | US5914395 Desmin enhancer sequences, vectors comprising these sequences and their uses in compositions for the expression of nucleotide sequences in transfected cells |
| 06/22/1999 | US5914390 Methods for increasing yields of recombinant proteins |
| 06/22/1999 | US5914348 Substance FA-70D, process for producing the same, and uses thereof |
| 06/22/1999 | US5914318 Transgenic plants expressing lepidopteran-active δ-endotoxins |
| 06/22/1999 | US5914317 A dna which hybridizes under high stringency conditions to a preferential dna sequence encodes b1k proteins which contains atleast thirty amino acid residues in length; useful for treating dermis disorder such as epidermal bulosis |
| 06/22/1999 | US5914315 Isolated amino acid sequences encoding a kunitz-type inhibitor; anticoagulants for treating deep vein thrombosis |
| 06/22/1999 | US5914270 Method for promoting the differentiation of plant cells in culture |
| 06/22/1999 | US5914261 Nucleic acid which codes for extracellular signal regulated kinase 1; for screening drugs for alzheimer's disease and other nervous system disorders; antidiabetic agents |
| 06/22/1999 | US5914252 Polype(tide found on the surface of synovial cells from patients with rheumatoid arthritis; for diagnostic reagents |
| 06/22/1999 | US5914251 Nucleic acid molecules encoding placental-derived growth factors |
| 06/22/1999 | US5914250 Gene which codes for mutant antibiotic having isoleucine substituted at 4 position of amino acid sequence |
| 06/22/1999 | US5914236 PCT-65 serotonin receptor |
| 06/22/1999 | US5914234 Methods of detecting growth differentiation factor-11 |
| 06/22/1999 | US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin |
| 06/22/1999 | US5914110 Contacting biological fluid sample of the patient suffering from excess immunoglobulins e production in a human with monoclonal antibody or fusion protein and detecting the presence or absence of complex of antibody and interleukin-4 |
| 06/22/1999 | US5914106 Interleukin-6 receptor agonists |
| 06/22/1999 | CA1340605C Isolation and characterization of telomere sequences of a.thaliana |
| 06/22/1999 | CA1340600C Bacillus thuringiensis p-2 toxin gene |
| 06/22/1999 | CA1340599C Antibiotic-producing microorganisms |
| 06/22/1999 | CA1340597C Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods |
| 06/17/1999 | WO1999029906A2 Gene family with transformation modulating activity |
| 06/17/1999 | WO1999029888A1 Humanization of murine antibody |
| 06/17/1999 | WO1999029879A1 VEGETABLE GntI SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY |
| 06/17/1999 | WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | WO1999029873A1 Cyclic gmp phosphodiesterase |
| 06/17/1999 | WO1999029870A1 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/17/1999 | WO1999029869A1 Compounds and methods for the diagnosis and treatment of b. microti infection |
| 06/17/1999 | WO1999029863A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | WO1999029860A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029856A1 Restin and methods of use thereof |
| 06/17/1999 | WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | WO1999029853A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | WO1999029849A1 G-protein coupled receptors associated with immune response |
| 06/17/1999 | WO1999029848A1 Novel vectors and genes exhibiting increased expression |
| 06/17/1999 | WO1999029843A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 06/17/1999 | WO1999029838A1 Fibrinogen-converting enzyme hybrids |
| 06/17/1999 | WO1999029834A1 Methods for preparation of vaccines against cancer |
| 06/17/1999 | WO1999029732A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/17/1999 | WO1999029730A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
| 06/17/1999 | WO1999029725A1 DNA MOLECULES ENCODING HUMAN NUCLEAR RECEPTOR PROTEIN, nNR5 |
| 06/17/1999 | WO1999029723A1 Recombinant nodavirus compositions and methods |
| 06/17/1999 | WO1999029722A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4 |
| 06/17/1999 | WO1999029721A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | WO1999029718A2 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof |
| 06/17/1999 | WO1999029717A2 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/17/1999 | WO1999029714A2 Organic chemical compounds and method for producing the same |
| 06/17/1999 | WO1999029340A1 An over-expressing homologous antigen vaccine and a method of making the same |
| 06/17/1999 | WO1999029182A1 Method for purifying heat shock peptides complexes |
| 06/17/1999 | WO1999019358A3 Antibody against baculoviruses |
| 06/17/1999 | WO1999017796A3 Modulation of lerk-2-mediated cell adhesion |
| 06/17/1999 | WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/17/1999 | CA2693296A1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 06/17/1999 | CA2317806A1 An over-expressing homologous antigen vaccine and a method of making the same |
| 06/17/1999 | CA2315273A1 Dna molecules encoding vertebrate nuclear receptor protein, nnr4 |
| 06/17/1999 | CA2314434A1 Dna molecules encoding human nuclear receptor protein, nnr5 |
| 06/17/1999 | CA2314267A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | CA2314005A1 Methods for preparation of vaccines against cancer |
| 06/17/1999 | CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/17/1999 | CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |
| 06/17/1999 | CA2313451A1 Cyclic gmp phosphodiesterase |
| 06/17/1999 | CA2313450A1 G-protein coupled receptors associated with immune response |
| 06/17/1999 | CA2313381A1 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof |
| 06/17/1999 | CA2313350A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2312734A1 Vegetable gnti sequences and the use thereof to obtain plants with a reduced or lack of n-acetylglucosaminyltransferase i (gnti) activity |
| 06/17/1999 | CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 06/17/1999 | CA2312476A1 Fibrinogen-converting enzyme hybrids |